In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana
Background. Cutaneous leishmaniasis causes physical disfigurement and impairment on affected individuals, however, little attention has been paid to it eradication. The situation of this neglected disease is complicated with the expansion of the non-human pathogenic Leishmania enriettii complex causing infection in humans. We have previously shown that the extract from Erythrophleum ivorense has leishmanicidal activity against promastigote stages of the L. enriettii complex isolate from Ghana and Leishmaniadonovani. The extract of E. ivorense has shown to have anti-inflammatory, wound-healing ability, antiallergic, antimalarial and antischistosomal activity. However, the concentration threshold of E. ivorense extract required for leishmanicidal activity against the emerging human pathogenic L. enriettii complex isolates is not clear.
Aim. To test for the concentration threshold of E. ivorense extract required to obtain ideal leishmanicidal activity against the promastigote stage of human pathogenic L. enriettii complex isolates from Ghana.
Method. The ethanolic leaf extract of E. ivorense was serially diluted and tested against the promastigote stage of the L. enriettii complex. Parasite inhibition was measured at 590 nm using a spectrophotometer after staining parasites with trypan blue. To select the threshold concentration for maximum inhibition of the promastigote stage of the L. enriettii complex, the concentration cut-off statistic was used.
Results. The MIC of E. ivorense extract for L. enriettii promastigote inhibition was 62.3 μg ml−1. The highest promastigote inhibition was observed at 72 h.
Conclusion. We show that a MIC of 62.3 μg ml−1 of E. ivorense leaf extract exhibits an ideal leishmanicidal activity against the promastigote stage of L. enriettii complex isolates.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BoampongJN,
AmeyawEO,
AboagyeB,
AsareK,
KyeiS et al. The Curative and Prophylactic Effects of Xylopic Acid on Plasmodium berghei Infection in Mice. J Parasitol Res2013; 2013:1–7 [View Article]
JohnsonNB,
AmeyawEO,
KyeiS,
AboagyeB,
AsareK et al. In vivo antimalarial activity of stem bark extracts of Plumeria alba against Plasmodium berghei in imprinting control region mice. Reports in parasitology2013; 3:19
YunC-H,
EstradaA,
Van KesselA,
ParkB-C,
LaarveldB.
Beta-Glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol Med Microbiol2003; 35:67–75 [View Article]
OliveiraAB,
DolabelaMF,
BragaFC,
JácomeRLRP,
VarottiFP et al. Plant-Derived antimalarial agents: new leads and efficient phythomedicines. Part I. alkaloids. An. Acad. Bras. Ciênc.2009; 81:715–740 [View Article]
Adu-AmoahL.
Antimicrobial and toxicity studies of erythrophleum ivorense (Leguminoseae) and parquetina nigrescens (Ascelpiadaceae). Doctoral dissertation2014
Kyere-DaviesG,
AgyareC,
BoakyeYD,
SuzukiBM,
CaffreyCR.
Effect of Phenotypic Screening of Extracts and Fractions of Erythrophleum ivorense Leaf and Stem Bark on Immature and Adult Stages of Schistosoma mansoni
. J Parasitol Res2018; 2018:1–7 [View Article]
ArmahFA,
AnnanK,
MensahAY,
AmponsahIK,
TocherDA et al. Erythroivorensin: a novel anti-inflammatory diterpene from the root-bark of Erythrophleum ivorense (a CheV.). Fitoterapia2015; 105:37–42 [View Article]
LairdSA.
The management of forests for timber and non-wood forest products in central Africa. Non-Wood Forest Products of Central Africa: Current Research Issues and Prospects for Conservation and Development. Food and Agriculture Organization Rome, Italy: of the United Nations; 1998 pp 51–60
AnningAS.
In vitro anti leishmanial activity of some selected medicinal plants in Ghana (Doctoral dissertation, University of Cape Coast).
ArmahFA,
AmponsahIK,
MensahAY,
DicksonRA,
SteenkampPA et al. Leishmanicidal activity of the root bark of Erythrophleum Ivorense (Fabaceae) and identification of some of its compounds by ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-QTOF-MS/MS). J Ethnopharmacol2018; 211:207–216 [View Article]
CavalliA,
BolognesiML.
Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania
. J Med Chem2009; 52:7339–7359 [View Article]
PrajapatiVK,
PandeyRK.
Recent advances in the chemotherapy of visceral leishmaniasis. InDrug design: Principles and applications Singapore: Springer; 2017 pp 69–.88
WebsterJP,
GowerCM,
KnowlesSCL,
MolyneuxDH,
FentonA.
One health - an ecological and evolutionary framework for tackling neglected zoonotic diseases. Evol Appl2016; 9:313–333 [View Article]
SundarS,
SinhaPK,
RaiM,
VermaDK,
NawinK et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet2011; 377:477–486 [View Article]
ParanaibaLF,
PinheiroLJ,
TorrecilhasAC,
MacedoDH,
Menezes-NetoA et al. Muniz & Medina, 1948: A highly diverse parasite is here to stay. PLoS pathogens2017; 13:e1006303
Kwakye-NuakoG,
MosoreM-T,
DuplessisC,
BatesMD,
PuplampuN et al. First isolation of a new species of Leishmania responsible for human cutaneous leishmaniasis in Ghana and classification in the Leishmania enriettii complex. Int J Parasitol2015; 45:679–684 [View Article]
IslamuddinM,
SahalD,
AfrinF.
Apoptosis-Like death in Leishmania donovani promastigotes induced by eugenol-rich oil of Syzygium aromaticum. J Med Microbiol2014; 63:74–85 [View Article]
WenzelUA.
Stage specific interactions of Leishmania major with host phagocytes. Doktorarbeit, research center Borstel, Leibniz-Center for medicine and biosciences, department of molecular infection biology. Division of Microbial Interface Biology2009
FerreiraTN,
Pita-PereiraD,
CostaSG,
BrazilRP,
MoraesCS et al. Transmission blocking sugar baits for the control of Leishmania development inside sand flies using environmentally friendly beta-glycosides and their aglycones. Parasit Vectors2018; 11:614 [View Article]
ChowdhuryKD,
SenG,
SarkarA,
BiswasT.
Role of endothelial dysfunction in modulating the plasma redox homeostasis in visceral leishmaniasis. Biochimica et Biophysica Acta (BBA) - General Subjects2011; 1810:652–665 [View Article]
VillinskiJT,
KlenaJD,
AbbassyM,
HoelDF,
PuplampuN et al. Evidence for a new species of Leishmania associated with a focal disease outbreak in Ghana. Diagn Microbiol Infect Dis2008; 60:323–327 [View Article]
FryauffDJ,
HanafiHA,
KlenaJD,
HoelDF,
AppawuM et al. Short report: ITS-1 DNA sequence confirmation of Leishmania major as a cause of cutaneous leishmaniasis from an outbreak focus in the HO district, southeastern Ghana. Am J Trop Med Hyg2006; 75:502–504 [View Article]
WakeelO,
UmukoroS,
KolawoleOT,
AweE,
AdemowoO.
Anticonvulsant and sedative activities of extracts of Erythrophleum ivorense stem bark in mice. AJBPS2014; 4:43
Loría-CerveraEN,
Andrade-NarváezFJ.
Animal models for the study of leishmaniasis immunology. Revista do Instituto de Medicina Tropical de São Paulo2014; 56:1–11 [View Article]
WakeelOK.
Analgesic, anti-inflammatory and anti-convulsant activities of stem bark extract of Erythrophleum ivorense (a CheV) in rats and mice. Doctoral dissertation University of Ibadan; Nigeria: 2014
AnsariNA,
SalujaS,
SalotraP.
Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin Immunol2006; 119:339–345 [View Article]
AshwinH,
SeifertK,
ForresterS,
BrownN,
MacDonaldS et al. Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis. Wellcome Open Res2018; 3:135 [View Article]
BhattacharyaP,
AliN.
Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis. Rev Soc Bras Med Trop2013; 46:128–134 [View Article]
FernándezOL,
Diaz-ToroY,
OvalleC,
ValderramaL,
MuvdiS et al. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS Negl Trop Dis2014; 8:e2871 [View Article]
AdauiV,
SchnorbuschK,
ZimicM,
GutiérrezA,
DecuypereS et al. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology2011; 138:183–193 [View Article]
GadisaE,
TsegawT,
AberaA,
ElnaiemD-E,
den BoerM et al. Eco-epidemiology of visceral leishmaniasis in Ethiopia. Parasit Vectors2015; 8:381 [View Article]
In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana